Biopharma investment and managment

Biopharma Investment and Management (BIM) is a boutique management consulting firm and contract research organization (CRO) founded in 2016. The company specializes in immunology, particularly immune-oncology and vaccinology, and serves technology transfer offices, biopharma companies, entrepreneurs, and investors. BIM offers a range of services including technical and business due diligence, IP strategy and management, business development support, and customized CRO-based R&D solutions. Their team, led by Dr. Lior Carmon, combines deep scientific expertise with business strategy to assist clients at both the strategic executive level and through hands-on R&D project management.

BIM aims to bridge the gap between scientific research and commercial success by tailoring competitive strategies and providing technical support to overcome day-to-day R&D challenges. By offering objective scientific validation, strategic guidance, and R&D training, the firm helps its clients optimize their return on investment, streamline development processes, and improve overall organizational performance. The company has a track record of supporting diverse projects ranging from early-stage seed ventures to established biopharma programs.